Dr. Irina Esterlis, PhD
Claim this profilePET Center
Studies Depression
Studies Major Depressive Disorder
3 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Irina Esterlis, PhD is currently running
Glutamate Imaging and Cognitive Testing
for Depression
This research study is designed to look at the involvement of the glutamate system in depression. Each subject will undergo a screening appointment to determine study eligibility. Thereafter, the study will take 2 or 3 visits depending on schedule availability and will consist of one MRI scan, and PET scan. Subjects will also participate in cognitive testing. Depending on camera time, staff availability and subject schedule, total study participation may last 1-2 months.
Recruiting1 award N/A6 criteria
Ketamine Imaging
for Mood Disorders
This study is designed to examine SV2A density in MDD and PTSD as a correlate of synaptic density, and to determine whether ketamine administration will reverse the synaptic loss in vivo in human subjects. To our knowledge, this is the first human study to examine SV2A in vivo in MDD and PTSD and to use the first known drug (ketamine) that rapidly reverses synaptic loss to determine whether ketamine administration could restore some of the structural changes associated with depression and PTSD. After a screening process to determine eligibility, all subjects will participate in an MRI, and 2-3 PET scans with the administration of ketamine for one of the scans. Cognitive testing and a stress test may also be done on scan days.
Recruiting1 award N/A2 criteria
More about Irina Esterlis, PhD
Clinical Trial Related8 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Irina Esterlis, PhD has experience with
- Cognitive Testing
- MRI
- PET
- Ketamine
- [11C]APP311
- [18F]FPEB
Breakdown of trials Irina Esterlis, PhD has run
Depression
Major Depressive Disorder
Problem Behavior
Bipolar Depression
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Irina Esterlis, PhD specialize in?
Irina Esterlis, PhD focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Irina Esterlis, PhD currently recruiting for clinical trials?
Yes, Irina Esterlis, PhD is currently recruiting for 2 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Irina Esterlis, PhD has studied deeply?
Yes, Irina Esterlis, PhD has studied treatments such as Cognitive Testing, MRI, PET.
What is the best way to schedule an appointment with Irina Esterlis, PhD?
Apply for one of the trials that Irina Esterlis, PhD is conducting.
What is the office address of Irina Esterlis, PhD?
The office of Irina Esterlis, PhD is located at: PET Center, New Haven, Connecticut 06519 United States. This is the address for their practice at the PET Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.